PCM
EIDX

Pentwater Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Pentwater Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-121,933
Closed -$16M – 410
2020
Q4 		$16M Buy
+121,933
New +$10.8M 0.19% 46

Pentwater Capital Management's EIDX Position: Q1 2021 in Review

Pentwater Capital Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 121,933 shares — an estimated $16M sold.

Pentwater Capital Management first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $16M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Pentwater Capital Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Pentwater Capital Management sold 121,933 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $16M.
  • Pentwater Capital Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Pentwater Capital Management's Eidos Therapeutics, Inc. Common Stock position peaked at $16M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.